Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus MonkeysXuebing Cao, Stella M. Papa, John R. Hadcock et al.|Journal of Pharmacology and Experimental Therapeutics|2007Cited by 101